Nanoparticle-Encapsulated Doxorubicin Demonstrates Superior Tumor Cell Kill in Triple Negative Breast Cancer Subtypes Intrinsically Resistant to Doxorubicin

Nanoparticle-Encapsulated Doxorubicin Demonstrates Superior Tumor Cell Kill in Triple Negative Breast Cancer Subtypes Intrinsically Resistant to Doxorubicin

<img src="https://s3.amazonaws.com/production.scholastica/article/6494/original/prnano_122018_ga.jpg?1547327627"> The effect of size and release kinetics of doxorubicin-nanoparticles on anti-tumor efficacy was evaluated in a panel of human cancer cell lines, including triple-negativ...

Full description

Bibliographic Details
Main Authors: Adam Friedman, Kenny Ye, Alicia Rodriguez-Gabin, Joshua Nosanchuk, Joel Friedman, Alan Alfieri, Mahantesh Navanti, Angelo Landriscina, Jamie Rosen, David Schairer, Joy Makdisi, Brandon Adler, Aimee Krausz, Hayley McDaid
Format: Article
Language:English
Published: Andover House Inc.
Series:Precision Nanomedicine
Online Access:http://prnano.scholasticahq.com/article/6494-nanoparticle-encapsulated-doxorubicin-demonstrates-superior-tumor-cell-kill-in-triple-negative-breast-cancer-subtypes-intrinsically-resistant-to-doxorubicin.pdf

Internet

http://prnano.scholasticahq.com/article/6494-nanoparticle-encapsulated-doxorubicin-demonstrates-superior-tumor-cell-kill-in-triple-negative-breast-cancer-subtypes-intrinsically-resistant-to-doxorubicin.pdf

Similar Items